| Description | This product is a Human GPIHBP1 membrane protein expressed in vitro E.coli expression system. The protein is for research use only and is not approved for use in humans or in clinical diagnosis. | Cynomolgus monkey is widely used in medical experiments, especially those associated with neuroscience and disease. This product is isolated from Cynomolgus monkey Bronchial/Tracheal tissue. Cells are negative for bacteria, yeast, fungi, mycoplasma, and can be used for a variety of tests and assays Cynomolgus monkey is widely used in medical experiments, especially those associated with neuroscience and disease. This product is isolated from Cynomolgus monkey Bronchial/Tracheal tissue. Cells are negative for bacteria, yeast, fungi, mycoplasma, and can be used for a variety of tests and assays such as cell-cell interaction, adhesion, migration, PCR, Western blot, immunoprecipitation, immunofluorescent staining, immunofluorescent flow cytometry, or generating cell derivatives for desired research applications.... Read More | Creative Biolabs offers a range of recombinant cell lines for Immunotherapy discovery and development. | This product GTTS-WK14445MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & Pseudo-UTP. It ecodes the AK124399 protein. This product can be used in CD1C-CD141- dendritic cell-related researches. | The product SIRGT90970WQ is a type of small interfering RNA (siRNA) that targets Plcl2 gene and regulates the expression of gene. The siRNA interferes with the expression of Plcl2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has The product SIRGT90970WQ is a type of small interfering RNA (siRNA) that targets Plcl2 gene and regulates the expression of gene. The siRNA interferes with the expression of Plcl2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More |